Evidence map›Paper›PMID 34389575›Full record

ArticleBMJ open2021

COVID-19-related stigma and its influencing factors: a nationwide cross-sectional study during the early stage of the pandemic in China.

Tianyu Jiang, Xudong Zhou, Leesa Lin, Yanzheng Pan, Yuyuan Zhong, Xiaomin Wang, Hui Zhu

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Tianyu JiangInstitute of Social Medicine, School of Medicine, Zhejiang University, Hangzhou, China.
Xudong ZhouInstitute of Social Medicine, School of Medicine, Zhejiang University, Hangzhou, China.ORCID 0000-0002-0784-5343
Leesa LinDepartment of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK.ORCID 0000-0003-4123-4762
Yanzheng PanInstitute of Social Medicine, School of Medicine, Zhejiang University, Hangzhou, China.
Yuyuan ZhongInstitute of Social Medicine, School of Medicine, Zhejiang University, Hangzhou, China.
Xiaomin Wang *Institute of Social Medicine, School of Medicine, Zhejiang University, Hangzhou, China xiaominwang2018@zju.edu.cn zhuhui2002@zju.edu.cn.ORCID 0000-0002-8918-6344
Hui Zhu *Institute of Social Medicine, School of Medicine, Zhejiang University, Hangzhou, China xiaominwang2018@zju.edu.cn zhuhui2002@zju.edu.cn.
Zhejiang University · CNLondon School of Hygiene & Tropical Medicine · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo describe the situation of COVID-19-related stigma towards patients with COVID-19 and people from the city of Wuhan in China and to assess the associations between COVID-19-related stigma, health literacy and sociodemographic characteristics during March 2020, the early stage of the pandemic.

designA cross-sectional online survey.

settingThe study surveyed 31 provinces in China.

participantsThis study surveyed 5039 respondents in China. OUTCOME MEASURES: Public stigma towards both patients with COVID-19 and Wuhan residents was measured. Binary logistic regression was used to identify the factors associated with public COVID-19-related stigma.

resultsAmong the participants, 122 (2.4%) reported themselves and 254 (5.0%) reported the communities they lived in as holding a stigmatising attitude towards patients with COVID-19, respectively. Additionally, 114 (2.5%) and 475 (10.3%) reported that themselves and the communities they lived in, respectively, held a stigma against people from Wuhan, which was the most severely affected area in China. People aged over 40, lived in areas with severe epidemics (adjusted OR (aOR)=2.03, 95% CI (1.05 to 3.92)) and who felt it difficult to find and understand information about COVID-19 (aOR=1.91, 95% CI (1.08 to 3.37); aOR=1.88, 95% CI (1.08 to 3.29)) were more likely to stigmatise patients with COVID-19. People who were male, aged 41-50 and had difficulty understanding information (aOR=2.08, 95% CI (1.17 to 3.69)) were more likely to stigmatise people from Wuhan.

conclusionsPatients with COVID-19 and Wuhan residents suffered stigma at both the individual and the community levels. Those who had low health literacy, who lived in areas with a large number of COVID-19 cases and who were of ethnic minorities were more likely to stigmatise others. Tailored interventions are encouraged to improve health literacy and consequently to reduce public COVID-19-related stigma.

Indexed as

COVID-19PandemicsChinaCross-Sectional StudiesHumansMaleSARS-CoV-2Surveys and QuestionnairesCOVID-19mental healthpublic health

Identifiers

PMID34389575
PMCPMC8366283
OpenAlexW3190885341

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.